PanTheryx announces new CEO and board chair

Tuesday January 14, 2020 0 comments Tags: Boulder, PanTheryx, Wes Parris, David Abramson, Mark Braman

BOULDER -- PanTheryx announced CEO Mark Braman is retiring and nutrition industry veteran Wes Parris, formerly of I-Health, Inc., will replace Braman as CEO effective immediately.

PanTheryx also announced the appointment of David Abramson to the board of directors, who will assume the role as executive chair.Pantheryx_logoUSE 

"We thank Mark for his service, leadership and for positioning the company for excellent growth,” said Craig Cogut, board chair.

“We wish him well in retirement. Moving forward, we enthusiastically welcome Wes and David. We believe their experience building leading wellness and nutrition brands will be a great benefit to the company in the future."

Parris brings more than a decade of executive experience within the health and wellness industry. As president and CEO of I-Health, Inc. (a subsidiary of DSM), he led all operations including sales, marketing, research and development, and business development.

During his almost 13 years with the company. Parris established and grew a category-leading consumer brand portfolio.

Parris is an alumnus of the University of North Carolina at Chapel Hill and Harvard Business School.

"I am thrilled to join PanTheryx at such a promising time in its growth and evolution,” said Parris.

“As nature’s perfect first food, colostrum has tremendous health benefits for all age groups. I believe PanTheryx employs the most stringent quality control measures to deliver best-in-class proprietary colostrum ingredients.

“These ingredients will be the backbone for new customer relationships and research and development efforts designed to bring transformative health and wellness solutions to consumers worldwide."

Abramson built a career in advising emerging growth, middle-market companies, and large multi-national companies primarily in the health and wellness and nutritional markets.

He was formerly president of Martek Biosciences Corporation (Nasdaq: MATK) where he played a key role in transitioning Martek's business from a research and development company to a fully-integrated commercial organization.

Abramson developed and implemented the branding strategy for Life's DHA, one of the most successful branded food ingredients, while leading efforts to include Life's DHA in over 500 commercial products.

The addition of Parris and Abramson follows a pivotal year in which the company announced that PanTheryx bovine colostrum was recognized as GRAS, key colostrum supply arrangements were inked with new customers, and a $50 million financing was secured to accelerate development of new products.